Injectable biodegradable polymeric system for preserving the active form and delayed-release of camptothecin anticancer drugs

RSC Advances

Volumn 2, Issue 1, 2012, Pages 176-185

  Mert, Olcay ^a,c   Esendali, Güne ^b   Doan, A Lale ^b   Demir, Ayhan S ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER DRUG; ATR FTIR; BRAIN TUMORS; BREAST TUMOR; CAMPTOTHECIN (CPT); CANCER CELL LINES; CYTOTOXIC; DRUG LOADING; IN-VIVO; LACTONE RINGS; PHYSIOLOGICAL CONDITION; POLYMERIC SYSTEMS; STABILIZATION MECHANISMS; SUSTAINED-RELEASE; THERMO SENSITIVE; TOPOTECAN; TUMOR SIZE;

BODY FLUIDS; CARBOXYLATION; CELL CULTURE; STABILIZATION; TUMORS;

MOTION PICTURE EXPERTS GROUP STANDARDS;

EID: 84859308887     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c1ra00366f     Document Type: Article

References (28)

1. B. Jeong Y. H. Bae D. S. Lee S. W. Kim Biodegradable block copolymers as injectable drug-delivery systems Nature 1997 388 6645 860 862
2. I.C. Kwon Y.H. Bae S.W. Kim Electrically erodible polymer gel for controlled release of drugs Nature 1991 354 291 293
3. R. Langer New Methods of Drug Delivery Science 1990 249 1527 1533
4. G. Chandrashekar N. Udupa Biodegradable injectable implant systems for long term drug delivery using poly (lactic-co-glycolic) acid copolymers J. Pharm. Pharmacol. 1996 48 7 669 74
5. C. I. Winternitz J. K. Jackson A. M. Oktaba H. M. Burt Development of a polymeric surgical paste formulation for taxol Pharm. Res. 1996 13 3 368 75
6. M. Katakam W.R. Ravis A.K. Banga Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels J. Controlled Release 1997 49 21 26
7. A. Bajpai, S. Shukla, R. Saini and A. Tiwari, Stimuli Responsive Drug Delivery Systems-From Introduction to Application, Smithers Rapra Technology, 2010
8. P. Tanner P. Baumann R. Enea O. Onaca C. Palivan W. Meier Polymeric Vesicles: From Drug Carriers to Nanoreactors and Artificial Organelles Acc. Chem. Res. 2011 44 10 1039 1049
9. C. Ferraro L. Quemeneur S. Fournel A. F. Prigent J. P. Revillard N. Bonnefoy-Berard The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes Cell Death Differ. 2000 7 2 197 206
10. J. Fassberg V. J. Stella A Kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some Analogs J. Pharm. Sci. 1992 81 7 676 684
11. M. C. Wani A. W. Nicholas G. Manikumar M. E. Wall Plant Antitumor Agents.25. Total Synthesis and Antileukemic Activity of Ring a Substituted Camptothecin Analogs-Structure Activity Correlations J. Med. Chem. 1987 30 10 1774 1779
12. M. C. Wani A. W. Nicholas M. E. Wall Plant Antitumor Agents.28. Resolution of a Key Tricyclic Synthon, 5′(Rs)-1,5-Dioxo-5′-Ethyl- 5′-Hydroxy-2′h,5′h,6′h-6′-Oxopyrano[3′, 4′-F]Delta-6,8-Tetrahydroindolizine-Total Synthesis and Antitumor-Activity of 20(S)-Camptothecin and 20(R)-Camptothecin J. Med. Chem. 1987 30 12 2317 2319
13. C. Jaxel K. W. Kohn M. C. Wani M. E. Wall Y. Pommier Structure-Activity Study of the Actions of Camptothecin Derivatives on Mammalian Topoisomerase-I-Evidence for a Specific Receptor-Site and a Relation to Antitumor-Activity Cancer Res. 1989 49 6 1465 1469
14. T. G. Burke, A. S. Demir, C. Tanyeli, A. J. Chavan, T. L. Wang, Y. Pommier, Water-soluble derivatives of camptothecin/homocamptothecin, US Pat., 2001, 6,291,676
15. T. G. Burke, A. S. Demir, A. J. Chavan, D. Yang, Oligonucleotide delivery systems for camptothecins, US Pat., 2005, 6,897,200
16. J. M. Gao J. Ming B. He Z. W. Gu X. D. Zhang Controlled release of 9-nitro-20(S)camptothecin from methoxy poly(ethylene glycol)-poly(d,l-lactide) micelles Biomed. Mater. 2008 3 15013
17. L. Yu G. T. Chang H. Zhang J. D. Ding Injectable block copolymer hydrogels for sustained release of a PEGylated drug Int. J. Pharm. 2008 348 1-2 95 106
18. M. Berrada A. Serreqi F. Dabbarh A. Owusu A. Gupta S. Lehnert A novel non-toxic camptothecin formulation for cancer chemotherapy Biomaterials 2005 26 14 2115 2120
19. O. Mert E. Doganci H. Y. Erbil A. S. Dernir Surface characterization of poly(l-lactic acid)-methoxy poly(ethylene glycol) diblock copolymers by static and dynamic contact angle measurements, FTIR, and ATR-FTIR Langmuir 2008 24 3 749 757
20. I. Chourpa J. M. Millot G. D. Sockalingum J. F. Riou M. Manfait Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy Biochim. Biophys. Acta, Gen. Subj. 1998 1379 3 353 366
21. D. L. Warner T. G. Burke Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs J. Chromatogr., Biomed. Appl. 1997 691 1 161 171
22. M. B. Hansen S. E. Nielsen K. Berg Re-Examination and Further Development of a Precise and Rapid Dye Method for Measuring Cell-Growth Cell Kill J. Immunol. Methods 1989 119 2 203 210
23. B. A. Pulaski and S. Ostrand-Rosenberg, Mouse 4T1 breast tumor model, Curr. Protoc. Immunol. 2001, ch. 20, unit 20.2
24. M. E. Wall, Alkaloids with antitumor activity. In International Symposium on Biochemistry and Physiology of the Alkaloids, ed., K. Mothes, K. Schreiber, and, H. R. Schutte, Academie-Verlag, Berlin, 1969, pp. 77-87
25. A. W. Nicholas M. C. Wani G. Manikumar M. E. Wall K. W. Kohn Y. Pommier Plant Antitumor Agents.29. Synthesis and Biological-Activity of Ring-D and Ring-E Modified Analogs of Camptothecin. Journal of Medicinal Chemistry 1990 33 3 972 978
26. H. Zhao C. Lee P. K. Sai Y. H. Choe M. Boro A. Pendri S. Y. Guan R. B. Greenwald 20-O-acylcamptothecin derivatives: Evidence for lactone stabilization J. Org. Chem. 2000 65 15 4601 4606
27. V. Kumar J. C. Kang R. J. Hohl Improved dissolution and cytotoxicity of camptothecin incorporated into oxidized-cellulose microspheres prepared by spray drying Pharm. Dev. Technol. 2001 6 3 459 467
28. S. S. Lin L. Sun Y. K. Zhang R. P. Zhao W. L. Liang S. T. Yuan L. Y. Zhang Topotecan inhibits cancer cell migration by down-regulation of chemokine CC motif receptor 7 and matrix metalloproteinases Acta Pharmacol. Sin. 2009 30 5 628 636